Bloomberg School of Public Health
Baltimore , Maryland
PhD, University of Minnesota, 1964
Current research interests involve design and conduct of clinical trials.
Other research interests involve writing Good Policy and Practices for Clinical Trials, as well as, writing about other methodologic issues in clinical trials.
Honors and Awards
1956 Phi Beta Kappa 1979 Fellow, American College of Epidemiology 1991 American Public Health Association Statistics Section Award 1993 Delta Omega Honorary Public Health Society 1995 Fellow, American Association for the Advancement of Science 2001 Fellow, American Heart Association 2006 Fellow, Society for Clinical Trials 2006 American Public Health Association Statistics Section Award
Clinical trials methodology
design and conduct of multicenter trial
- Meinert CL, Breitner JCS: Chronic disease long-term prevention trials: Lessons from the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT). Alzheimer's & Dementia 4: S7-S14, 2008.
Meinert CL: Long-term drug prevention trials. Clin Trials 5:168-176, 2008
Ünalp A, Tonascia S, Meinert CL: Presentation in realtion to publication of results from clinical trials. Contemp Clin Trials 28:359-369, 2007
Lyketsos CG, Breitner JCS, Green RC, Martin BK, Meinert CL, Piantadosi S, Sabbagh M: Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology 68:1-1, 2007
Schwartz TB and Meinert CL: The UGDP Controversy: Thirty-four years of contentious ambiguity laid to rest. Perspect Biol Med 47(4):564-574, 2004